From: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré
Results
AS/AQ (n = 102)
AS/SP (n = 99)
N
%
95%CI
Early Treatment failure
0
0–3.5
1
0–5.5
Late Treatment Failure
1.0
0–3.7
Total failure
0–5.3
ACPR
101
99.0
94.7–99.8
98
94.5–99.8